New Heart Failure Trials

Clinical trials focused on heart failure research, exploring new therapies and treatment strategies. Some of these trials aim to address unmet needs or build upon existing knowledge to improve heart failure management.

EMPEROR-Preserved: This trial investigated the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with heart failure and preserved ejection fraction (HFpEF). The study assessed the potential benefits of this drug in reducing heart failure hospitalizations and improving cardiovascular outcomes in this specific patient population.

GALACTIC-HF: This global trial evaluated the efficacy and safety of omecamtiv mecarbil, a novel cardiac myosin activator, in patients with heart failure and reduced ejection fraction (HFrEF). The study aimed to determine whether this new therapy could improve cardiac function and reduce heart failure-related events.

VICTORIA: This trial investigated the use of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic heart failure. The study examined the drug's potential to reduce cardiovascular death and heart failure hospitalization rates.

These trials and others are crucial in advancing the understanding of heart failure and identifying new treatment options that could potentially benefit patients in the future. It's essential to consult the latest scientific literature or clinical trial registries for updates and results.

    Related Conference of New Heart Failure Trials

    September 25-26, 2023

    17th International Congress on Autoimmunity

    Prague, Czech Republic
    October 09-10, 2023

    2nd International Conference on World Heart Care

    Zurich, Switzerland
    October 16-17, 2023

    4th Annual Summit on Cardiology and Heart Diseases

    Toronto, Canada
    October 26-27, 2023

    27th World Cardiology Conference

    Toronto, Canada
    October 30-31, 2023

    6th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    November 13-14, 2023

    35th Annual Cardiologists Conference

    Barcelona, Spain
    November 15-16, 2023

    38thEuropean Cardiology Conference

    Barcelona, Spain
    November 16-17, 2023

    Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    November 20-21, 2023

    11th International Heart Conference

    Dubai, UAE
    November 20-21, 2023

    4th Global Summit On Heart Congress

    Dubai, UAE
    November 23-24, 2023

    5th Euro Cardiology Congress

    Amsterdam, Netherlands
    November 27-28, 2023

    31st World Heartcare Summit

    Montreal, Canada
    January 25-26, 2024

    39th World Cardiology Conference

    London, UK
    February 08-09, 2024

    3rd International Conference on Cardiology

    Paris, France
    March 07-08, 2024

    38th World Congress on Heart Diseases

    Paris, France
    March 11-12, 2024

    13th World Heart Congress

    Paris, France
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France

    New Heart Failure Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in